|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of goods Sold | |||
| Inventory write-down | |||
| Total Cost of Revenue | |||
| Gross Profit | |||
| General and administrative expenses | |||
| Selling and Distribution expenses | |||
| Depreciation and Amortisation | |||
| Operating loss | |||
| Other income, net | |||
| Finance Expenses | |||
| Loss before income taxes | |||
| Income tax expense/benefit | |||
| Net loss attributable to common stockholders | |||
| Loss attributable to Common Stock holders of Parent Company | |||
| Loss attributable to non-controlling interests | |||
| Loss per share attributable to common stockholders, Basic | |||
| Loss per share attributable to common stockholders, Diluted | |||
| Weighted-average number of shares used in computing loss per share amounts, Basic | |||
| Weighted-average number of shares used in computing loss per share amounts, Diluted | |||
| Foreign currency translation adjustments | |||
| Remeasurements of the net defined benefit liability / asset, net | |||
| Comprehensive income |
Loading...
